Institutional investors purchased a net $4.2 million shares of SYN during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 14.18% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
KNOLL CAPITAL MANAGEMENT LP Bought 1.4 Million shares of Synthetic Biologics Inc
BELMONT GLOBAL ADVISORS, INC. Bought 1.3 Million shares of Synthetic Biologics Inc